Drug Topics
FEBRUARY 23, 2024
During a session at the Outcomes 2024 SYNC National Conference, Pacience Edwards, PharmD, manager of compliance at Outcomes, discussed the impacts that advancements in technology have had on pharmacy.
STAT
FEBRUARY 23, 2024
Hospitals, pharmacies, and other health care providers are getting stuck in an insurance processing logjam after UnitedHealth Group disclosed a cyberattack within a recently acquired subsidiary that serves as a central hub for payments across the industry. The cyberattack and subsequent system outage within UnitedHealth’s Change Healthcare has caught the attention of federal law enforcement agencies.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
FEBRUARY 23, 2024
With over 3% of the world’s population affected by chronic hepatitis B, TherVacB has the potential to address a critical unmet need for a cure.
pharmaphorum
FEBRUARY 23, 2024
Explore the opportunities and challenges facing rare disease therapies developers, including the impact of Rare Disease Day, FDA regulations, and cutting-edge technologies like CRISPR gene therapy.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
FEBRUARY 23, 2024
Manufacturer ARS Pharma will submit the data as part of a response to a CRL received in 2023.
Pharmacy Times
FEBRUARY 23, 2024
The evolution of pharmacy, as a practice and profession, is unique in that its evolution has quickened exponentially in just the past 20 years.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
FEBRUARY 23, 2024
Kay Kay Lineweaver’s first birthing experience in 2021 didn’t go as planned. Her baby was breech and the doctor wouldn’t allow her to try to give birth vaginally, so she ended up with an unwanted cesarean section. “[The obstetrician] wouldn’t even give me the option,” she recalled later in a podcast called “Healing Trauma Mamas.
Fierce Pharma
FEBRUARY 23, 2024
A narrow miss in a confirmatory trial has | Along with host of other positive recommendations, European drug regulators rendered a positive opinion on Travere's Filspari for full approval in Berger’s disease.
STAT
FEBRUARY 23, 2024
WASHINGTON — Colorado is pioneering a new way for states to crack down on prescription drug costs. In a first-in-the-nation move, a state board voted to create a payment limit for a widely prescribed Amgen drug used to treat arthritis, a step that may usher in a new era in which state governments take more aggressive action to control the cost of prescription medicines.
Fierce Pharma
FEBRUARY 23, 2024
Even Alexander Hardy, the former Genentech leader who managed the blockbuster hemophilia drug Hemlibra, can’t immediately bend the laggard launch trajectory of BioMarin’s gene therapy Roctavian.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
pharmaphorum
FEBRUARY 23, 2024
Bavarian Nordic will get an accelerated review of its chikungunya vaccine CHIKV VLP at the EMA, as it tries to chase down a lead held by rival Valneva. The Danish pharma group said it is planning to file for approval of its vaccine in the first half of this year, adding the EU regulator’s human medicine committee, the CHMP, has said it will cut the review time from 210 to 150 days under its accelerated assessment procedure.
Fierce Healthcare
FEBRUARY 23, 2024
Under the False Claims Act, more than $1.8 billion in settlements and judgments was related to health-related matters in the last fiscal year, about two-thirds of the monetary fraud recoveries by t | Health fraud settlements under the False Claims Act exceeded $1.8 billion last year, according to the Department of Justice. The agency said it is still litigating Medicare Advantage cases against major insurers.
Pharmacy Times
FEBRUARY 23, 2024
Investing in community relationships and health literacy are key steps pharmacists can take to improve equity.
Fierce Healthcare
FEBRUARY 23, 2024
Walgreens is closing its remaining VillageMD primary care clinics in Florida. | The announcement does not come as a total surprise, as Walgreens first disclosed its plans to close 60 underperforming VillageMD clinics and exit five markets last fall.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Pharma
FEBRUARY 23, 2024
As the Biden administration’s exploration of “march-in rights" draws support from powerful entities like the Federal Trade Commission (FTC), a group of lawmakers on both sides of the aisle have war | As the Biden administration’s exploration of “march-in rights" draws support from powerful entities like the Federal Trade Commission, a small group of lawmakers on both sides of the aisle have warned the approach could “hamstring” U.S. innovation.
Fierce Healthcare
FEBRUARY 23, 2024
Broadly speaking, the hospital sector is a much stronger state financially than it was in 2022 or even early 2023 amid industry reports of higher medians and margin improvements being shared by sev | A review of hospitals' 2023 operating numbers show 40% are still losing money going into 2024 and that high-performing hospitals are "effectively pulling away from the pack," according to a recent Kaufman Hall analysis.
Fierce Pharma
FEBRUARY 23, 2024
Teva and Alvotech have braved a long and winding road on the quest to win approval for their biosimilar to AbbVie’s Humira. | Teva and Alvotech have braved a long and winding road on the quest to win approval for their biosimilar to AbbVie’s Humira. Now, after multiple manufacturing setbacks, the partners have finally scored their inaugural regulatory nod in the United States.
pharmaphorum
FEBRUARY 23, 2024
AI software developed by Israeli medtech Magentiq-Eye has been shown to improve detection rates for adenoma, a precursor to colorectal cancer, in colonoscopy procedures
Fierce Pharma
FEBRUARY 23, 2024
Following a contentious advisory committee meeting and an FDA request for the withdrawal of Oncopeptides’ multiple myeloma drug Pepaxto from the U.S. | Following a contentious advisory committee meeting and an FDA request for withdrawal of Oncopeptides’ multiple myeloma drug Pepaxto from the U.S. market in late 2022, the other shoe has dropped.
pharmaphorum
FEBRUARY 23, 2024
The FDA has started a priority review of Sanofi and Regeneron’s Dupixent as a treatment for chronic obstructive pulmonary disease (COPD), which could become the first new treatment for the widespread and life-threatening disease in over a decade.
Fierce Healthcare
FEBRUARY 23, 2024
Online therapy company Talkspace is doubling down on its strategy to grow its business with payers and employers with a focus on providing services to teens and seniors. | Online therapy company Talkspace is doubling down on its strategy to grow its business with payers and employers with a focus on providing services to teens and seniors.
Pharmacy Times
FEBRUARY 23, 2024
Four years after congress passed it, the Hannon Act is helping veterans get better care
PharmaVoice
FEBRUARY 23, 2024
Following Moderna’s COVID-19 vaccine success, therapeutics head Dr. Kyle Holen discusses scaling mRNA development to bring candidates to the finish line in oncology and more.
Drug Store News
FEBRUARY 23, 2024
Staffing in some independent pharmacies is continuing to be a challenge, with 67% saying it’s difficult to fill open staff positions, according to the NCPA survey.
The Checkup by Singlecare
FEBRUARY 23, 2024
Ashwagandha, also known as Indian winter cherry or Indian ginseng, is a relatively small, unassuming plant—an evergreen shrub with greenish-gray oval leaves. Yet, this herb holds a very important place in Ayurvedic medicine, a system of traditional medicine with deep roots in India that aims to prevent disease and keep the mind, body, and spirit in balance.
Fierce Healthcare
FEBRUARY 23, 2024
A federal judge has denied HCA Healthcare’s motion to dismiss antitrust litigation brought by North Carolina cities and counties related to the for-profit’s 2019 acquisition of Mission Health. | Local governments allege that HCA acquired Mission Health in 2019 to "exploit" its monopoly power, which they say has led to higher prices and budget cuts.
STAT
FEBRUARY 23, 2024
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda appears quite modest so far. We plan to promenade with the official mascots, catch up on our napping and maybe finish an overdue library book. There might also be a listening party, and the rotation will likely include this , this , this , this and this.
Fierce Pharma
FEBRUARY 23, 2024
This week on “The Top Line,” we explore the impact of environmental, social and governance measures, commonly known as ESG, on the pharmaceutical industry. | This week on "The Top Line," we explore the impact of environmental, social, and governance measures, commonly known as ESG, on the pharmaceutical industry. Fierce Pharma's Fraiser Kansteiner engages in a conversation with Jim Greffet, Head of ESG Strategy at Eli Lilly, to gain insights and discuss Lilly's specific ESG
STAT
FEBRUARY 23, 2024
This week, an encouraging turnaround for Ocular Therapeutix, a chat with Alnylam’s CEO defending changes to the HELIOS-B study and talking up its hypertension treatment, and quick takes on Amylyx and obesity stocks. A Worst CEO gets some much-needed help For most of last year, Ocular Therapeutix CEO Antony Mattessich promised shareholders that he was close to nailing down a lucrative pharma partnership that would pay for late-stage clinical trials of the company’s treatments for de
Drug Store News
FEBRUARY 23, 2024
The retailer is now collaborating with Grubhub to offer an assortment of thousands of wellness, beauty, household and other convenience items on the Grubhub Marketplace.
Drug Topics
FEBRUARY 23, 2024
Large pharmacy benefit managers have switched up their coverage of biosimilars this year—especially for biosimilars to adalimumab.
Fierce Healthcare
FEBRUARY 23, 2024
Just a few short months after making a push into the payer space, digital health company Waltz Health is stepping into the Medicare market. | Just a few short months after making a push into the payer space, digital health company Waltz Health is stepping into the Medicare market.
STAT
FEBRUARY 23, 2024
In a victory for the pharmaceutical industry, Oregon officials have suspended a portion of a contentious state law designed to bring more transparency to prescription drug pricing. For now, the Oregon Department of Consumer and Business Services will no longer require drug companies to compile annual reports on price increases, a key feature of a transparency law that was enacted in 2018.
Drug Store News
FEBRUARY 23, 2024
How does retail pharmacy capture spending of millennials and Gen Z customers who seek convenience and digital connectivity?
Expert insights. Personalized for you.
196 
Let's personalize your content